Cite
HARVARD Citation
Haas, L. et al. (n.d.). P147 IMPLEMENTATION OF A NEW ORAL CONTRAST AGENT FOR CT AND MR ENTEROGRAPHY IN PEDIATRIC IBD CLINICAL PRACTICE: IMPACT ON TOLERABILITY, DISTENSION, IMAGE QUALITY AND DIAGNOSTIC CONFIDENCE. Inflammatory bowel diseases. pp. S53-S54. [Online].